Atlas Trials

Study of BCMA CAR-T in Multiple Myeloma

Clinical trial NCT03559764 · UNKNOWN

Trial details

NCT number
NCT03559764
Sponsor
Allife Medical Science and Technology Co., Ltd.
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Relapsed and Refractory Multiple Myeloma
Start date
2018-06-01
Primary completion
2020-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.